Ginkgo Bioworks and Genomatica join forces

Christophe Schilling
Christophe Schilling

Ginkgo Bioworks and Genomatica announced an alliance to more rapidly deliver biology-based solutions for the world’s highest-volume intermediate and specialty chemicals. Mainstream chemical producers can now in-license technology to manufacture their widely-used chemicals with cost-effective and sustainable whole-process solutions that include engineered microorganisms, complete process designs and technology transfer support. The alliance is structured as a deep collaboration, with two-way sharing of technology and intellectual property, along with joint technology development, to provide a single unified offering to the market.

Continue reading

Supporting Catia Bastioli. The bioeconomy is democracy

bastioli-a-bottrighe-2She has created the Italian bioeconomy. Thanks to her passion, her tenacity, her ability, Italy today can rightly claim to be a leading country in this field. All this in the total lack of an Italian strategy on bioeconomy.

The inauguration last Friday of Mater Biotech’s plant in Bottrighe di Adria, the first in the world capable of producing butanediol from renewable sources, is her umpteenth great victory. The demonstration that the bioeconomy is a reality, that creates wealth and jobs in an environmentally friendly way. That the goals can be achieved with passion and determination, putting into practice a new idea of sustainable enterprise.

Continue reading

Novamont opens world’s first commercial-scale bio-BDO plant in North-eastern Italy  

Catia Bastioli, Ceo of Novamont

Mater Biotech, a 100% company owned by Novamont, today proved Genomatica’s revolutionary technology that converts renewable feedstocks into 1,4 butendiol (BDO) at the Grand Opening of its first commercial bio-BDO plant in Bottrighe di Adria (Rovigo, Italy).

Continue reading

Clariant and Global Bioenergies: first isobutene production from a wheat straw hydrolysate

Hariolf Kottmann, Ceo of Clariant
Hariolf Kottmann, Ceo of Clariant

Global Bioenergies and Clariant announced yesterday the first isobutene production from a wheat straw hydrolysate, in the industrial pilot of Pomacle Bazancourt, France. This is the result of a collaboration initiated more than 18 months ago, and has been made possible by combining Clariant’s proprietary process, allowing for the conversion of agricultural residues into sugar-rich hydrolysates, with Global Bioenergies’ proprietary process for the production of isobutene from various industrial-grade sugars.

Continue reading

Global Bioenergies, Preem, Sekab and Sveaskog join forces to develop forest-based fuel

Marc Delcourt, co-founder and CEO of Global Bioenergies
Marc Delcourt, co-founder and CEO of Global Bioenergies

Global Bioenergies, Preem, Sekab and Sveaskog yesterday announced having joined forces to develop a high-performance fuel entirely based on forest resources. The consortium has signed a collaboration agreement to carry out a conceptual scope study for a first plant in Sweden. This work will be carried out as part of the “Bio-Based Gasoline Project” with support from the Swedish Energy Agency.

Continue reading

Virent, Tesoro, Toray, Johnson Matthey and The Coca-Cola Company join forces

The Coca-Cola Company pavilion at Expo Milano 2015
The Coca-Cola Company pavilion at Expo Milano 2015

Virent established a strategic Consortium with Tesoro, Toray, Johnson Matthey and The Coca-Cola Company focused on completing the development and scale up of Virent’s BioForming® technology to produce low carbon bio-based fuels and bio-paraxylene (a key raw material for the production of 100% bio-polyester). The Consortium members will work together to finalize technical developments and commercial arrangements, with the objective of delivering a commercial facility to produce cost effective, bio-based fuels and bio-paraxylene.

Continue reading

IFIB 2016: Sustainability is the single largest business opportunity of this generation

Henri Colens, Braskem Europe
Henri Colens, Braskem Europe

The bioeconomy is alive and is set to grow. This is the strong message coming from Vicenza, Italy, where last Thursday and Friday was held the sixth edition of IFIB, the Italian Forum on Industrial Biotechnology and Bioeconomy.

About 300 participants. Among them some of the big global companies active in the bioeconomy: Braskem, Dow, Novamont, NatureWorks, Mossi Ghisolfi, Clariant, GFBiochemicals and Carlsberg. Innovative start-ups, universities and research centers, as well as clusters such as Clib2021 (Germany), IAR Pole (France) and Bio-based Delta (Netherlands). And again: OECD, European Investment Bank, German Bioeconomy Council.

“Sustainability – Rafael Cayuela, Chief Economist at Dow Chemical, stated – is a huge technological challenge but also the single largest business opportunity of this generation”.

Continue reading

The U.S. bioeconomy is alive and well. New report by BIO

Tom Vilsack and Barack Obama
Tom Vilsack and Barack Obama

The U.S. Biotechnology Innovation Organization (BIO) released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and outlining federal and state policies that support the industry.

Continue reading

Renmatix announced a $14 million investment led by Bill Gates

Mike Hamilton, Ceo of Renmatix
Mike Hamilton, Ceo of Renmatix

Renmatix, the U.S. leader in affordable cellulosic sugars headquartered in King of Prussia (Pennsylvania), announced a $14 million investment, led by Bill Gates. Industry demand for competitive alternatives to petro-derived molecules is gaining traction, despite recent market pressures. In the interest of expanding that supply, the Plantrose® process provides an enabling technology for profitable biorefineries. This investment in commercializing Plantrose will help drive towards the first wave of Renmatix licensees building Plantrose-enabled biorefineries in diverse global markets like Canada, India, Malaysia, the U.S. and elsewhere. In parallel, that activity will facilitate further market development in downstream bioproduct applications.

Continue reading

Novozymes acquires German microbial research company Organobalance

Novozymes Headquarter
Novozymes Headquarter

Novozymes, Danish biotech giant, today announced the acquisition of microbial research company Organobalance GmbH for an undisclosed amount. Germany-based Organobalance owns a large collection of microbial strains, some of which date back to the 1920s, and has strong capabilities in microbial screening and assay technology. It specializes in developing natural microbial solutions for customers and partners across a number of industries including food, feed, and animal health.

Continue reading